Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume

Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 11,000 shares of GNOM short. Learn More on Global X Genomics & Biotechnology ETF's current short interest.

Global X Genomics & Biotechnology ETF saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 11,000 shares, a decrease of 77.9% from the previous total of 49,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: VanEck Digital Transformation ETF (2.11%), WisdomTree Cybersecurity Fund (0.00%), First Trust Indxx Innovative Transaction & Process ETF (0.01%), Wahed Dow Jones Islamic World ETF (0.09%), ERShares Entrepreneurs ETF (0.06%), SPDR MSCI ACWI Climate Paris Aligned ETF (0.56%), Valkyrie Bitcoin Miners ETF (0.15%), iShares ESG Advanced MSCI EM ETF (0.27%), Siren Nasdaq NexGen Economy ETF (0.08%), CrossingBridge Pre-Merger SPAC ETF (1.70%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is March, 31 2024.